EV/EBITDA
-3.09
-0.10-3.34%
Fri, 29 Nov 2024 20:58:42 GMT
Summary:
Tango Therapeutics EV/EBITDA is currently -3.09, with a fall of -0.10 (-3.34%) during the most recent trading day. Over the past year, it has increased by +3.52 (+53.25%). TNGX EV/EBITDA is now -60.10% below its all-time high of -1.93.TNGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -3.3% |
| 1 m1 month | +32.5% |
| 3 m3 months | +65.9% |
| 6 m6 months | +45.3% |
| ytdytd | +64.9% |
| 1 y1 year | +53.3% |
| 5 y5 years | - |
TNGX EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -2.20 | -40.5% | -4.58 | +32.5% |
| 3 m | 3 months | -2.20 | -40.5% | -9.62 | +67.9% |
| 6 m | 6 months | -2.20 | -40.5% | -9.62 | +67.9% |
| 1 y | 1 year | -2.20 | -40.5% | -11.79 | +73.8% |
| 3 y | 3 years | -1.93 | -60.1% | -17.84 | +82.7% |
| 5 y | 5 years | -1.93 | -60.1% | -23.77 | +87.0% |
| alltime | all time | -1.93 | -60.1% | -23.77 | +87.0% |
Tango Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.09(-64.9%) |
| 2023 | -8.81(+55.4%) |
| Date | Value |
|---|---|
| 2022 | -5.67(-60.2%) |
| 2021 | -14.26 |
FAQ
- What is Tango Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Tango Therapeutics?
- What is TNGX EV/EBITDA year-to-date change?
- What is Tango Therapeutics EV/EBITDA year-on-year change?
What is Tango Therapeutics EV/EBITDA?
The current EV/EBITDA of TNGX is -3.09
What is the all time high EV/EBITDA for Tango Therapeutics?
Tango Therapeutics all-time high EV/EBITDA is -1.93
What is TNGX EV/EBITDA year-to-date change?
Tango Therapeutics EV/EBITDA has changed by +5.72 (+64.93%) since the beginning of the year
What is Tango Therapeutics EV/EBITDA year-on-year change?
Over the past year, TNGX EV/EBITDA has changed by +3.52 (+53.25%)